Class II — Diasorin Inc.
| Recalling firm | DiaSorin Inc. |
|---|---|
| Registered facility | View this company's 5 registered facilities → (openFDA recall records do not name a specific facility) |
| Classification | Class II |
| Status | Ongoing |
| Reason | Printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value |
| Product | Parvovirus B19 IgG EIA kit Part No. V519IGUS |
| Quantity | 615 units |
| Distribution | NJ, WI, NY, NC, MN, CA, IL, VA, MA, MI, CT Canada |
| Initiated | 2020-07-17 |
| Classified | 2020-09-03 |
| Recall number | Z-2936-2020 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — Diasorin Inc. (Z-2936-2020).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/86152/
Alerts for DiaSorin Inc.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.